SUMMARY In vitro lymphocyte adhesion to, and selective radiosulphate uptake by, endothelial cells has been demonstrated in diseased synovium of patients with rheumatoid disease, osteoarthritis, and the peripheral arthropathy associated with ankylosing spondylitis and ulcerative colitis. These characteristics have been described previously in endothelial cells functionally specialised for promoting lymphocyte traffic from blood to lymph node parenchyma. It is suggested that these observations indicate that some synovial vessels may be responsible, at least in part, for the selective accumulation of lymphocytes in the tissue. Manipulation of the development of this type of vessel may offer a novel way of influencing the progress of inflammatory arthropathies.
It is believed that lymphocytes derived from the recirculating pool may modulate tissue damage in chronic inflammatory arthropathies,1 2 but the mechanisms by which these cells enter synovium are poorly understood. It has been proposed that changes observed in local venules in sites of lymphocyte accumulation in diseased synovium may indicate endothelial specialisation for promoting selective lymphocyte traffic between blood and tissue parenchyma.3 In support of this proposal it has been noted that these vessels have the morphological and histochemical properties of human lymph node high endothelial venules (HEV),4 which are the exclusive site of lymphocyte traffic from blood to nodal parenchyma. HEV are known to influence lymphocyte traffic via a series of complex endothelial-lymphocyte interactions mediated, in part, by macromolecules produced by their endothelial cells (HEC). -8 Two of these interactions, calcium dependent binding of lymphocytes to HEC5 6 and secretion by HEC of a sulphated glycolipid7 8 which will induce lymphocyte migration into skin if injected intradermally, can be assayed in vitro; the first, by measurement of the adhesion of lymphocytes to the cut surface of HEV in lymph node slices5 6; and the The obvious similarities between lymph node HEV and the HEV-like vessels in diseased synovium have lead to speculation that they may be functionally similar,3 and in particular that the mechanisms governing endothelial-lymphocyte interactions may be the same. In the study reported here this possibility has been examined by comparing in vitro lymphocyte adhesion and sulphate uptake in human lymph node HEV and synovial HEV-like vessels.
Materials and methods
The study material consisted of 10 human lymph nodes and 20 synovial biopsy specimens. The 
Results
Four of the seven synovia from patients with rheumatoid arthritis (RA), one of the two with ankylosing spondylitis (AS), that from the patient with ulcerative colitis, and one of those with osteoarthritis (OA) contained areas of lymphocyte aggregation on at least one of the sections examined for lymphocyte adhesion and for sulphate uptake. One of the patients with RA, the remaining patient with AS, and seven of the OA group had no areas of lymphocyte aggregation on any of the preparations used in the study (Table 1) .
Lymphocyte adhesion and sulphate uptake were seen in lymph node HEV and some, but not all, vessels within areas of lymphocyte accumulation in all the diseased synovia (Fig. 1) . No lymphocyte adhesion or sulphate uptake was seen in vessels other than HEV in lymph nodes or in vessels outside areas of lymphocyte accumulation in diseased synovium (Tables 2 and 3 ).
The vessels in the synovium to which lymphocytes adhered and those that took up sulphate had the (Table 4) .
No HEV in the lymph nodes scored less than + + +, whereas lymphocyte adhesion and sulphate uptake in synovium occurred in vessels designated + + and + + +. In lymph nodes and synovium there was a significant difference in both lymphocyte adhesion and sulphate uptake between vessels of score + and + + + (p<0-001) and in synovium between vessels of + and + + (p=0-02) and + + and + + + (p=0-.01). The variation in overall lymphocyte adhesion and sulphate uptake between vessels in lymph nodes and synovium can therefore be explained, at least in part, by the heterogeneity of HEV-like vessels in synovium. There was, however, a significant difference also between lymph node HEV and synovial HEV-like vessels of score + + + for both lymphocyte adhesion and sulphate uptake (p<0-01), perhaps indicating that factors other than endothelial area may be influencing these manifestations of 'HEC-ness'. Monoclonal antibodies have been developed against the lymphocyte recognition site of HEC6 10 which prevent in vitro binding of lymphocytes. Early evidence from studies using these antibodies suggests that receptor mediated lymphocyte homing is organ specific. 0 1' In their study of lymphocyte adhesion to rheumatoid synovial vessels Jalkanen et al produced some evidence to sugzest that this specificity may extend to synovium. ' This observation could be exploited therapeutically. It is conceivable that by using these or similar antibodies to inhibit selective lymphocyte adhesion to synovial blood vessels or by interfering with synthesis of the sulphated macromolecule implicated in endothelial control of lymphocyte traffic it may be possible to reduce lymphocyte accumulation within diseased synovium. This could offer a novel approach to limiting tissue damage in all synovitides in which synovial injury is mediated through lymphocytes. 
